Regional blood flow occlusion during extensive pelvic procedures for ovarian cancer: A randomized trial

International Journal of Gynecological Cancer

Volumn 14, Issue 4, 2004, Pages 699-705

  Eisenkop, Scott M ^a   Spirtos, N M ^b   Lin, W M ^a   Rafidi, F ^c   Gross, G M ^d  

^a Women's Cancer Center   (United States)

^b Women's Cancer Center   (United States)

^c Vascular Group   (United States)

^d Huntsville Vascular Specialists PC   (United States)

Author keywords

Morbidity; Ovarian cancer cytoreduction

Indexed keywords

HISTAMINE; PROTAMINE;

ADULT; AGED; AORTA OCCLUSION; ARTERY CLAMP; ARTICLE; BLOOD FLOW; BLOOD TRANSFUSION; CANCER SURGERY; CLINICAL TRIAL; COLON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENITAL SYSTEM; HOSPITALIZATION; HUMAN; INTERNAL ILIAC ARTERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MODIFIED POSTERIOR PELVIS EXENTERATION; MORBIDITY; OPERATION DURATION; OVARY CANCER; PELVIS EXENTERATION; PERITONEUM; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; AORTA; BLOOD LOSS, SURGICAL; CONSTRICTION; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HEMOSTASIS, SURGICAL; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; REGIONAL BLOOD FLOW; TIME FACTORS; VASCULAR SURGICAL PROCEDURES;

EID: 4043139435     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1048-891X.2004.14426.x     Document Type: Article

References (26)

1. Guidozzi F, Ball JH. Extensive primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol 1994;53:326-30.
2. Sopher JT, Couchman G, Berchuck A, Clarke-Pearson D. The role of partial sigmoid colectomy for debulking epithelial ovarian cancer. Gynecol Oncol 1991;41:239-44.
3. Barnes W, Johnson J, Waggoner S, Barter J, Potkul R, Delgado G. Reverse hysterocolposigmoidectomy (RHCS) for resection of panpelvic tumors. Gynecol Oncol 1991;42:151-5.
4. Hertel H, Diebolder H, Herrmann J et al. Is the decision for colorectal resection justified by histopathologic findings: a prospective study of 100 patients with advanced ovarian cancer. Gynecol Oncol 2001;83:481-4.
5. Obermair A, Hagenauer S, Tamandl D et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 2001;83:115-20.
6. Berek JS, Hacker NF, Lagasse LD. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet Gynecol 1986;64:715-20.
7. Eisenkop SM, Nalick RH, Teng NNH. Modified posterior exenteration for ovarian cancer. Obstet Gynecol 1991;78:879-85.
8. Eisenkop SM, Spirtos NM. Procedures required to accomplish complete cytoreduction for ovarian cancer. Is there a correlation with 'biological aggressiveness' and survival? Gynecol Oncol 2001;82:435-41.
9. Eisenkop SM, Spirtos NM, Lin WM, Gross GM. Reduction of blood loss during extensive pelvic procedures by aortic clamping - a preliminary study. Gynecol Oncol 2003;88:80-4.
10. Rutherford R. In: Vascular Surgery. Philadelphia: W.B. Saunders; 2000.
11. Eisenkop SM, Spirtos NM. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol Oncol 2001;82:489-97.
12. Arango HA, Hoffman MS, Roberts WS et al. Does ligation of the hypogastric artery at the time of radical hysterectomy and lymphadenectomy decrease blood loss? Results of a prospective randomized trial. Int J Gynecol Cancer 2000;10:173-8.
13. Morrow CP, Curtin JP. Surgery for ovarian neoplasia. In: Gynecologic Cancer Surgery. New York: Churchill Livingstone; 1996.
14. Patsner B. Radical abdominal hysterectomy using the ENDO-GIA stapler: report of 150 cases and literature review. Eur J Gynaecol Oncol 1998;19:215-9.
15. Brewer CA, Chan J, Kurosaki T, Berman ML. Radical hysterectomy with the endoscopic stapler. Gynecol Oncol 1998;71:50-2.
16. Eisenkop SM, Friedman RL, Wang H. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998;69:103-6.
17. Bristow RE, Tomacruz RS, Armstrong DK, Trimble ELS, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59.
18. Eisenkop SM, Nalick RH, Wang H, Teng NNH. Peritoneal implant elimination during cytoreductive surgery for ovarian cancer: impact on survival. Gynecol Oncol 1993;51:224-9.
19. Montz FJ, Schlaerth JB, Berek JS. Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer. Gynecol Oncol 1989;35:338-40.
20. Rose PG. The cavitronal ultrasonic surgical aspirator for cytoreduction in advanced ovarian cancer. Am J Obstet Gynecol 1992;166:843-6.
21. Spirtos NM, Gross GM, Freddo JL, Ballon SC. Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 1995;56:345-52.
22. Benedetti-Panici P, Scambia G, Baiocchi G. Technique and feasibility of radical para-aortic and pelvic lymphadenectomy for gynecologic malignancies: a prospective study. Int J Gynecol Cancer 1991;133:1-6.
23. Nicklin JL, Copeland LJ, O'Toole RV, Lewandowski GS, Vaccarello L, Havenar LP. Splenectomy as part of cytoreductive surgery for ovarian carcinoma. Gynecol Oncol 1995;58:244-7.
24. Schwartz SI. Trauma and liver. In: Principles of Surgery. New York: McGraw-Hill; 1999.
25. Marshall FF. Partial nephrectomy. In: Textbook of Operative Urology. Philadelphia: W.B. Saunders; 1996.
26. Scarabelli C, Imparto E, Biffignandi F, Aspesi G. Hypogastric vein ligation during oncologic surgery as thromboembolic disease prevention. Eur J Gynaecol Oncol 1988;9:270-2.